When was Trial Library founded?

Trial Library was founded in 2018 and raised its 1st funding round 4 years after it was founded.

Where is Trial Library located?

Trial Library is headquartered in San Francisco, United States.

How many employees does Trial Library have?

As of Aug 31, 2026, the latest employee count at Trial Library is 39.

Is Trial Library a funded company?

Trial Library is a funded company, having raised a total of $15M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Aug 18, 2022.

When was the latest funding round of Trial Library?

Trial Library's latest funding was a $***** Series A round on Dec 02, 2025, with participation from 7 investors. Its primary sector is Biopharma Outsourcing. In United States, the Biopharma Outsourcing sector has seen $749M in funding in 2026 to date.

Where does Trial Library rank among its competitors?

Trial Library ranks 18th amongst 885 active competitors, of which 61 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Helogen, which secured $7.1M in Sep, 2026.

Who are the top competitors of Trial Library?

Trial Library's top competitors include Alloy Therapeutics, Adimab and Simulations Plus. Among them, Helogen secured the most recent funding round in September, 2026.

Trial Library - 2026 Company Profile, Funding & Competitors

Most viewed in 2019

Trial Library is a series A company based in San Francisco (United States), founded in 2018. It operates as a Provider of clinical trial for drug research & development services. Trial Library has raised $15M in funding from NEXT VENTURES and SemperVirens. The company has 885 active competitors, including 61 funded and 50 that have exited. Its top competitors include companies like Alloy Therapeutics, Adimab and Simulations Plus.

Key Metrics

Founded Year

2018

Location

San Francisco, United States

Stage

Series A

Total Funding

$15M in 2 rounds

Latest Funding Round

Series A, Dec 02, 2025, $*****

Investors

NEXT VENTURES & 11 more

Ranked

18^th among 885 active competitors

Employee Count

39 as on Aug 31, 2026

Similar Companies

Alloy Therapeutics & 906 more

View Trial Library's full profile

Trial Library has raised a total funding of $15M over 2 rounds. Its first funding round was on Aug 18, 2022. Its latest funding round was a Series A round on Dec 02, 2025 for $*****. 7 investors participated in its latest round. Trial Library has 10 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of Trial Library:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 02, 2025	5140109	Series A	2029693	2439229	3207128	4356084
Aug 18, 2022	8448786	Seed	9860052	3181656	Deena Shakir	Julian Eison & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Trial Library's funding rounds and investors

Trial Library's employee count trend

Trial Library has 39 employees as of Aug 26. Here is Trial Library's employee count trend over the years:

Uncover Trial Library's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Trial Library include Alloy Therapeutics, Adimab and Simulations Plus. Here is the list of Top 10 competitors of Trial Library, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Alloy Therapeutics 2017, Lexington (United States), Series E	Provider of drug discovery services	$157M	8VC, Mubadala & 11 others	69/100
2nd	Adimab 2007, Series F	Developer of yeast based discovery platforms for therapeutic protein engineering	$35.4M	Polaris Partners, SV Health Investors & 10 others	65/100
3rd	Simulations Plus 1996, Lancaster (United States), Acquired	Developer of modeling and simulation software and consulting services provider	-	FDA, NIH & 1 others	60/100
4th	Sygnature Discovery 2004, Nottingham (United Kingdom), Series A	Provider of integrated drug discovery and development research services	-	Rothschild & Co, Torreal & 4 others	56/100
5th	Manifold Bio 2018, United States, Series A	Developer of tissue-targeted therapeutics using in vivo screening and AI design	$78.2M	Playground Global, Triatomic & 8 others	54/100
6th	CILcare 2014, Montpellier (France), Series A	Service to develop health products aiming to diagnose, prevent, delay the progression or treat hearing loss and tinnitus	$42.3M	Shionogi, Galia Gestion & 5 others	54/100
7th	Biocom California 1995, San Diego (United States), Acquired	CRO focused on drug discovery & development for multiple therapeutic areas	-	-	52/100
8th	Helogen 2024, Mountain View (United States), Seed	Provider of space-based biomanufacturing and drug discovery services	$7.1M	RRE Ventures, Blisce & 3 others	52/100
9th	Viva Biotech 2006, Shanghai (China), Public	Research services focused on drug discovery and development	-	Temasek, Spinnotec & 3 others	51/100
10th	Superluminal Medicines 2022, Boston (United States), Series B	Generative biological and chemical company focused on drug discovery	$223M	RA Capital Management, BVF Partners & 9 others	51/100
18th	Trial Library 2018, San Francisco (United States), Series A	Provider of clinical trial for drug research & development services	$15M	Sanofi Ventures, NEXT VENTURES & 10 others	48/100